Probiotics as beneficial agents in the management of diabetes mellitus: A systematic review

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 2, 2016, Pages 143-168

  Razmpoosh, Elham ^a   Javadi, Maryam ^a   Ejtahed, Hanieh Sadat ^b,c   Mirmiran, Parvin ^d,e  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Hyperglycemia; Lipid profile; Onset of diabetes; Probiotics

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; PROBIOTIC AGENT;

ANTIDIABETIC ACTIVITY; ARTICLE; COCHRANE LIBRARY; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LACTOBACILLUS; MEDLINE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCOPUS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DISEASE MANAGEMENT;

DIABETES MELLITUS; DISEASE MANAGEMENT; HUMANS; PROBIOTICS;

EID: 84958168077     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2665     Document Type: Article

References (90)

1. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141(6): 421-431.
2. IDF. International Diabetes Federation: Diabetes Atlas. 2013.
3. Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31(Suppl 1): S61-S78.
4. Gebel E. American Diabetes Association: the pros and cons of dietary supplements. 2012.
5. Bhathena J, Martoni C, Kulamarva A, et al. Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1b golden Syrian hamsters. PLoS One 2013; 8(3): e58394.
6. Lindsay KL, Kennelly M, Culliton M, et al. Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (probiotics in pregnancy study). Am J Clin Nutr 2014; 99(6): 1432-1439.
7. Asemi Z, Zare Z, Shakeri H, Sabihi SS, Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, Hs-Crp, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013; 63(1-2): 1-9.
8. Nitert MD, Barrett HL, Foxcroft K, et al. Spring: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women. BMC Pregnancy Childbirth 2013; 13: 50.
9. Yadav H, Jain S, Yadav M. Probiotics and diabetes/obesity. Bioactive Food as Dietary Interventions for Diabetes: Bioactive Foods in Chronic Disease States 2012; 307-317.
10. FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001.
11. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5(2): e9085.
12. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using Kk-Ay mice. Endocr J 1997; 44(3): 357-365.
13. Matsuzaki T, Nagata Y, Kado S, Uchida K, Hashimoto S, Yokokura T. Effect of Oral Administration of Lactobacillus Casei on Alloxan-Induced Diabetes in Mice. APMIS 1997; 105(8): 637-642.
14. Lin CH, Lin CC, Shibu MA, et al. Oral lactobacillus reuteri Gmn-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus. Br J Nutr 2014; 111(4): 598-605.
15. Ejtahed HS, Mohtadi Nia J, Homayouni Rad A, Niafar M, Asghari Jafarabadi M, Mofid V. The effects of probiotic and conventional yoghurt on diabetes markers and insulin resistance in type 2 diabetic patients: a randomized controlled clinical trial. Iranian J Endocrinol Metab 2011; 13(1): 112.
16. Mazloom Z, Yousefinejad A, Dabaghmanaesh MH. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial. Iranian J Med Sci 2013; 38(1): 38-43.
17. Firouzi S, Barakatun-Nisak MY, Ismail A, Majid HA, Nor Azmi K. Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies. Int J Food Sci Nutr 2013; 64(6): 780-786.
18. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27(suppl 1): s88-s90.
19. Harisa GI, Taha EI, Khalil AF, Salem MM. Oral administration of Lactobacillus acidophilus restores nitric oxide level in diabetic rats. Aust J Basic Appl Sci 2009; 3(3): 2963-2969.
20. Lu YC, Yin LT, Chang WT, Huang JS. Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats. J Biosci Bioeng 2010; 110(6): 709-715.
21. Manirarora JN, Parnell SA, Hu YH, Kosiewicz MM, Alard P. NOD dendritic cells stimulated with Lactobacilli preferentially produce Il-10 versus Il-12 and decrease diabetes incidence. Clin Dev Immunol 2011; 630187. DOI: 10.1155/2011/630187
22. Yadav H, Jain S, Sinha PR. Effect of Skim Milk and Dahi (Yogurt) on Blood Glucose, Insulin, and Lipid Profile in Rats Fed with High Fructose Diet. J Med Food 2006; 9(3): 328-335.
23. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17(1): 1-12.
24. Sotto A, Laouini D, Bouziges N, Jourdan N, Richard JL, Lavigne JP. in Vitro Activity of Daptomycin against Strains Isolated from Diabetic Foot Ulcers. Pathol Biol (Paris) 2010; 58(1): 73-77.
25. Teruya K, Yamashita M, Tominaga R, et al. Fermented milk, Kefram-Kefir enhances glucose uptake into insulin-responsive muscle cells. Cytotechnology 2002; 40(1-3): 107-116.
26. Xie W, Gu D, Li J, Cui K, Zhang Y. Effects and action mechanisms of berberine and Rhizoma coptidis on Gut microbes and obesity in high-Fat diet-Fed C57bl/6j mice. PLoS One 2011; 6(9): e24520.
27. Kingma SDK, Li N, Sun F, Valladares RB, Neu J, Lorca GL. Lactobacillus johnsonii N6.2 stimulates the innate immune response through toll-like receptor 9 in Caco-2 cells and increases intestinal crypt paneth cell number in biobreeding diabetes-prone rats. J Nutr 2011; 141(6): 1023-1028.
28. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in Gut microflora improve high-Fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia 2007; 50(11): 2374-2383.
29. Chen JJ, Wang R, Li XF, Wang RL. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med (Maywood) 2011; 236(7): 823-831.
30. Chen SW, Zhong J, Huan LD. Expression of human insulin in lactic acid bacteria and its oral administration in non-obese diabetic mice. Wei Sheng Wu Xue Bao 2007; 47(6): 987-991.
31. Click RE. A 60-Day Probiotic Protocol with Dietzia Subsp. C79793-74 Prevents Development of Johne's Disease Parameters after in Utero and/or Neonatal Map Infection. Virulence 2011; 2(4): 337-347.
32. Click RE. Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: adaption to chronic human diarrheal diseases. Virulence 2011; 2(2): 131-143.
33. Connolly ML, Tuohy KM, Lovegrove JA. Wholegrain oat-based cereals have prebiotic potential and low glycaemic index. Br J Nutr 2012; 108(12): 2198-2206.
34. Ankolekar C, Pinto M, Greene D, Shetty K. Phenolic Bioactive Modulation by Lactobacillus Acidophilus Mediated Fermentation of Cherry Extracts for Anti-Diabetic Functionality, Helicobacter Pylori Inhibition and Probiotic Bifidobacterium Longum Stimulation. Food Biotechnol 2011; 25(4): 305-335.
35. An H, Park S, Lee D, et al. Antiobesity and lipid-lowering effects of Bifidobacterium Spp. In high fat diet-induced obese rats. Lipids Health Dis 2011; 10(1): 116.
36. Naito E, Yoshida Y, Makino K, et al. Beneficial effect of oral administration of Lactobacillus casei strain shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 2011; 110(3): 650-657.
37. Everard A, Matamoros S, Geurts L, Delzenne NM, Cani PD. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, Low-grade inflammation, and Fat mass in obese and type 2 diabetic Db/Db mice. MBio 2014; 5(3): e01011-e01014.
38. Yadav H, Jain S, Sinha PR. The Effect of Probiotic Dahi Containing Lactobacillus Acidophilus and Lactobacillus Casei on Gastropathic Consequences in Diabetic Rats. J Med Food 2008; 11(1): 62-68.
39. Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 2014; 33(2): 198-203.
40. Kim ST, Kim HB, Lee KH, et al. Steam-dried ginseng berry fermented with Lactobacillus plantarum controls the increase of blood glucose and body weight in type 2 obese diabetic db/db mice. J Agric Food Chem 2012; 60(21): 5438-5445.
41. Laleye SA, Igbakin AP, Akinyanju JA. Antidiabetic effect of Nono (a Nigerian fermented milk) on alloxan-induced diabetic rats. Am J Food Technol 2008; 3(6): 394-398.
42. Roselino MN, Pauly-Silveira ND, Cavallini DC, et al. A potential synbiotic product improves the lipid profile of diabetic rats. Lipids Health Dis 2012; 11: 114.
43. Moroti C, Souza Magri LF, de Rezende CM, Cavallini DC, Sivieri K. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis 2012; 11: 29.
44. Costabile A, Klinder A, Fava F, et al. Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr 2008; 99(1): 110-120.
45. Davari S, Talaei SA, Salami M, Fazeli MR, Alaei H. Effects of supplementation with probiotics on long-term potentiation impairment in diabetic rats. J Isfahan Med Sch 2013; 30(218): 2236-2247.
46. Davari S, Talaei SA, Soltani M, Alaei H, Salami M. The effect of co-administration of Lactobacillus probiotics and Bifidobacterium on spatial memory and learning in diabetic rats. Tehran Univ Med J 2012; 70(9): 531-539.
47. Xu Z, Wang R, Yang Y, Dai R, Shang J, Yu Q. Intervention effect of probiotic Bifidobacterium on type 2 diabetes mellitus rats. Wei Sheng Yan Jiu 2014; 43(2): 277-281, 285.
48. Ghoneim MA, Moselhy SS. Impact of probiotic-supplemented diet on the expression level of lactate dehydrogenase in the leukocytes of rabbits. Toxicol Ind Health 2014; 30(3): 225-232.
49. Pandey P, Mishra A, Agrawal IS. Influence of dietary supplementation of antibiotic and probiotic on rumen nitrogen metabolism, blood glucose and certain hematological parameters in crossbred bullocks. Indian J Anim Sci 2009; 79(10): 1081-1082.
50. Gobel RJ, Larsen N, Jakobsen M, Molgaard C, Michaelsen KF. Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. J Pediatr Gastroenterol Nutr 2012; 55(6): 673-678.
51. Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr 2010; 103(12): 1792-1799.
52. Asemi Z, Samimi M, Tabassi Z, et al. Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial. Eur J Clin Nutr 2013; 67(1): 71-74.
53. Barrett HL, Callaway LK, Nitert MD. Probiotics: a potential role in the prevention of gestational diabetes? Acta Diabetol 2012; 49(1): 1-13.
54. Maioli M, Pes GM, Sanna M, et al. Sourdough-leavened bread improves postprandial glucose and insulin plasma levels in subjects with impaired glucose tolerance. Acta Diabetol 2008; 45(2): 91-96.
55. Ham JS, Jeong SG, Noh YB, et al. Effect of milk containing Streptococcus thermophilus KACC 91147 on blood glucose levels. Korean J Food Sci Anim Resour 2007; 27(4): 496-500.
56. Gonchar NV, Mel'nikova I, Il'ina TV, Rudenko NN, Udalova AN. Correction of secondary hyperlipidemia in children with diabetes. Eksp Klin Gastroenterol 2012; 1: 34-37.
57. Mueting D, Ordnung W. Lactobacillus bifidus milk for patients with chronic liver disease with or without diabetes. Erfahrungen Mit Einer Neuen Bifidum Milch Bei Chronisch Leberkraken Mit Und Ohne Diabetes 1976; 26(10): 1590-1595.
58. Mykhal'chyshyn HP, Bodnar PM, Kobyliak NM. Effect of probiotics on proinflammatory cytokines level in patients with type 2 diabetes and nonalcoholic fatty liver disease. Lik Sprava 2013; 2: 56-62.
59. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010; 104(12): 1831-1838.
60. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012; 28(5): 539-543.
61. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011; 94(7): 3288-3294.
62. Mohamadshahi M, Veissi M, Haidari F, Shahbazian H, Kaydani GA, Mohammadi F. Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. Bioimpacts 2014; 4(2): 83-88.
63. Huang HY, Korivi M, Tsai CH, Yang JH, Tsai YC. Supplementation of Lactobacillus plantarum K68 and fruit-vegetable ferment along with high fat-fructose diet attenuates metabolic syndrome in rats with insulin resistance. Evid Based Complement Alternat Med 2013; 2013: 943020.
64. Marazza JA, LeBlanc JG, de Giori GS, Garro MS. Soymilk fermented with Lactobacillus rhamnosus Crl981 ameliorates hyperglycemia, lipid profiles and increases antioxidant enzyme activities in diabetic mice. J Funct Food 2013; 5(4): 1848-1853.
65. Al-Salami H, Butt G, Fawcett JP, Tucker IG, Golocorbin-Kon S, Mikov M. Probiotic Treatment Reduces Blood Glucose Leveis and Increases Systemic Absorption of Gliclazide in Diabetic Rats. Eur J Drug Metab Pharmacokinet 2008; 33(2): 101-106.
66. Andersson U, Branning C, Ahrne S, et al. Probiotics lower plasma glucose in the high-fat fed C57bl/6j mouse. Benef Microbes 2010; 1(2): 189-196.
67. Bejar W, Hamden K, Ben Salah R, Chouayekh H. Lactobacillus plantarum Tn627 significantly reduces complications of alloxan-induced diabetes in rats. Anaerobe 2013; 24: 4-11.
68. Calcinaro F, Dionisi S, Marinaro M, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005; 48(8): 1565-1575.
69. Davari S, Talaei SA, Alaei H, Salami M. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience 2013; 240: 287-296.
70. Honda K, Moto M, Uchida N, He F, Hashizume N. Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J Clin Biochem Nutr 2012; 51(2): 96-101.
71. Hsieh FC, Lee CL, Chai CY, Chen WT, Lu YC, Wu CS. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab (Lond) 2013; 10(1): 35.
72. Matsuzaki T, Nagata Y, Kado S, et al. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 1997; 105(8): 643-649.
73. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using Kk-a(Y) mice. Endocr J 1997; 44(3): 357-365.
74. Tabuchi M, Ozaki M, Tamura A, et al. Antidiabetic Effect of Lactobacillus Gg in Streptozotocin-Induced Diabetic Rats. Biosci Biotechnol Biochem 2003; 67(6): 1421-1424.
75. Tanida M, Imanishi K, Akashi H, et al. Injection of Lactobacillus casei strain shirota affects autonomic nerve activities in a tissue-specific manner, and regulates glucose and lipid metabolism in rats. J Diabetes Investig 2014; 5(2): 153-161.
76. Tomaro-Duchesneau C, Saha S, Malhotra M, et al. Effect of orally administered L. Fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Appl Microbiol Biotechnol 2014; 98(1): 115-126.
77. Valladares R, Sankar D, Li N, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 2010; 5(5e10507).
78. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007; 23(1): 62-68.
79. Yadav H, Jain S, Sinha PR. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res 2008; 75(2): 189-195.
80. Yamano T, Tanida M, Niijima A, et al. Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sci 2006; 79(20): 1963-1967.
81. Yun SI, Park HO, Kang JH. Effect of Lactobacillus gasseri Bnr17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 2009; 107(5): 1681-1686.
82. Zarfeshani A, Khaza'ai H, Mohd Ali R, Hambali Z, Wahle KWJ, Mutalib MSA. Effect of Lactobacillus casei on the production of pro-inflammatory markers in streptozotocin-induced diabetic rats. Probiotics Antimicrob Proteins 2011; 3(3-4): 168-174.
83. Zhang Y, Wang L, Zhang J, et al. Probiotic Lactobacillus Casei Zhang Ameliorates High-Fructose-Induced Impaired Glucose Tolerance in Hyperinsulinemia Rats. Eur J Nutr 2014; 4: 1-6.
84. El-Khamisy AES. Effect of Bifidobacterium and Lactobacillus acidophilus in diabetic rats. The 5th Arab and 2nd International Annual Scientific Conference; Mansoura University, Egypt. 2010.
85. Mathers JC, Fernandez F, Hill MJ, McCarthy PT, Shearer MJ, Oxley A. Dietary modification of potential vitamin K supply from enteric bacterial menaquinones in rats. Br J Nutr 1990; 63(3): 639-652.
86. Choi HJ, Yu J, Choi H, et al. Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care 2011; 34(9): e147.
87. Yoshida M, Jacques PF, Meigs JB, et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008; 31(11): 2092-2096.
88. Ooi LG, Liong MT. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 2010; 11(6): 2499-2522.
89. Maritim AC, Sanders RA, Watkins JBIII. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17(1): 24-38.
90. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010; 107(9): 1058-1070.